V8 Peptides — Engineered Performance
Research Library
Semaglutide Shelf Life: Designing a Stability Check
SemaglutideReconstitution & Handling

Semaglutide Shelf Life: Designing a Stability Check

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

How long does a research semaglutide vial stay stable? No validated shelf life has been published for research-grade lyophilized semaglutide reconstituted in a laboratory diluent, so no day-count should be quoted as fact. What the literature supports is a framework: the dry powder is far more stable than solution, degradation of a lipidated peptide proceeds through hydrolysis, deamidation, oxidation and aggregation, and the only way to know the state of a particular stock is to measure it. The product page gives the storage line: refrigerate at 2–8 °C, −20 °C for long-term, protect from heat, moisture and light. This guide shows how a laboratory can design its own stability check. For laboratory research use only.

Shelf-life questions are the most common storage question for any peptide, and the honest answer for a research vial is usually "it depends on how you measure it". The companion page semaglutide storage and stability covers the practical tiers. This article takes a different angle: it explains how stability is defined, which degradation routes are relevant to a lipidated 31-residue peptide, and how a laboratory can build a small in-house study that answers the question for its own conditions, using formula-only arithmetic and published analytical principles.

What shelf life means and what it does not

In formulation science a shelf life is a claim supported by a stability study: defined lots, defined storage conditions, defined time points and defined acceptance criteria for purity, potency and appearance. It is not a property of a molecule alone. The same peptide can be stable for years as a lyophilized solid and for hours in a dilute solution at room temperature. A date quoted without a method is an opinion. Wang (1999) and Manning and colleagues (2010) both stress that stability is a joint outcome of the molecule, the formulation and the storage conditions, which is why the numbers published for a finished, buffered medicinal product do not transfer to a research vial reconstituted in water.

Degradation routes relevant to semaglutide

Semaglutide is a 31-residue peptide with a C18 fatty diacid on lysine 26 and an α-aminoisobutyric acid at position 8 (Lau and colleagues, 2015). Four classes of change are relevant to a laboratory.

RouteWhat happensConditions that favor itHow it is detected
HydrolysisPeptide bond cleavage, yielding fragmentsExtreme pH, heat, time in solutionReversed-phase HPLC (new early or late peaks); mass spectrometry
Deamidation and isomerizationAsparagine or glutamine converts to acid forms; aspartate can isomerize (Geiger and Clarke, 1987)Neutral to basic pH, warmthCharge-sensitive chromatography; small mass shift of about 1 Da
OxidationSusceptible side chains such as methionine, tryptophan, histidineLight, trace metals, peroxides in excipientsMass shift of +16 Da; HPLC shoulder peaks
AggregationSelf-association through the fatty chain and hydrophobic surfacesAgitation, freeze–thaw, high concentration, interfacesSize-exclusion chromatography; turbidity; light scattering

Aggregation deserves particular attention for lipidated peptides because the side chain makes the molecule surface-active. Foaming and vigorous mixing introduce air–water interfaces, and freezing introduces ice–liquid interfaces (Bhatnagar and colleagues, 2007). Both can start aggregation that later looks like a loss of purity or activity.

Why solution stability is a separate question from powder stability

Water takes part in most chemical degradation reactions and also lets peptide molecules move and meet. Removing it by lyophilization slows nearly everything. Once powder is reconstituted, the clock for those routes starts. Preservative in the diluent, such as the benzyl alcohol in bacteriostatic water, limits microbial growth but does nothing for chemical stability, and in a few assays it interferes with the system. The difference between the two diluents is explained in bacteriostatic water explained, and how long do reconstituted peptides last covers the general reasoning.

Designing a small in-house stability check

A laboratory that depends on a stock for weeks can answer the question empirically. The design below is deliberately modest.

  1. Define the question. For example: does the stock held at 2–8 °C for a given interval still show the same main-peak share and concentration as a fresh preparation?
  2. Prepare once, divide immediately. Make a single stock and divide it into identical low-binding tubes, so that every time point comes from the same preparation.
  3. Assign storage arms. At minimum: a time-zero sample analyzed at once, a refrigerated arm and a frozen arm. Add a room-temperature arm only if the bench use warrants it.
  4. Choose time points before you start. Write the sampling schedule in the notebook, and take one tube per arm per point so no tube is entered twice.
  5. Analyze together. Run all time points in one HPLC sequence at the end so that instrument drift does not masquerade as degradation.
  6. Set acceptance criteria in advance. For example, a maximum change in main-peak area percentage and in measured concentration relative to time zero.
  7. Record appearance. Clarity, color and particulates at every point, since a failed visual check ends the arm.

Hawe and colleagues (2012) describe forced-degradation approaches, such as heat, light and agitation stress, which can be added to see what the degradation products look like and to confirm that the HPLC method can actually separate them from the main peak. That property, called stability-indicating, is what makes the numbers meaningful.

Formulas used in the check

All the arithmetic is simple, and no per-product table is needed. Stock concentration in mg/mL equals vial mass in mg divided by diluent volume in mL. Recovery at a time point equals measured concentration divided by time-zero concentration, expressed as a percentage. Main-peak purity equals main-peak area divided by total integrated area. Use the reconstitution calculator for the first formula, and keep the calculation of the others in the same notebook page as the raw data so that the study can be audited later. For net-content correction, consult the certificate where one is published in the COA library.

Variables that confound a stability result

  • Adsorption. Loss to tube walls looks like degradation in a concentration measurement. Use low-binding tubes and keep dilute samples short-lived (Goebel-Stengel and colleagues, 2011).
  • Evaporation. Small volumes in loosely capped tubes concentrate over time and can mask loss.
  • Freeze–thaw. Count the cycles for every tube, since a repeatedly frozen portion is a different sample from a once-frozen one.
  • Light. Keep all arms boxed unless light is the variable being tested.
  • Method variability. Run replicate samples and report the spread, so a change smaller than method noise is not over-read.

What published data exist

Stability information for semaglutide in the literature mostly concerns the formulated, buffered product and its manufacturing and analytical control. The discovery paper characterizes the molecule's design, and Knudsen and Lau (2019) review the development path. None of these provides a degradation rate for a research-grade vial reconstituted in water or bacteriostatic water, so a laboratory should regard any such figure found online with caution. The checks on semaglutide purity testing describe how to read an HPLC trace once you have one.

Storage states and what is known about each

StateTemperature tierEvidence status
Sealed lyophilized vial in use soon2–8 °CConsistent with the product page; solid-state stability is generally good but not quantified for this material
Sealed reserve vial−20 °CProduct page long-term tier; use a constant-temperature freezer rather than a frost-free unit
Reconstituted stock, refrigerated2–8 °CNo published research-grade shelf life; measure if the stock must be held
Reconstituted stock, frozen in portions−20 °COne freeze–thaw cycle planned; aggregation risk rises with each additional cycle
Working dilution in bufferPrepare on the dayLow concentration increases adsorption loss; discard leftovers

The table makes one point clearly: the further a sample is from the dry, cold, dark state, the more the laboratory's own data should replace assumption. Where an experiment depends on an exact concentration over weeks, a short stability check is cheaper than a repeated run with a drifting stock.

Practical storage rules that follow from the evidence

  • Keep sealed powder cold, dry and boxed, as the product page states.
  • Let a cold vial reach room temperature before opening to avoid condensation.
  • Reconstitute gently by running diluent down the wall; do not shake or vortex (see semaglutide reconstitution and handling).
  • Divide stock into single-use portions if it will be kept beyond a few uses.
  • Label with compound, lot, diluent, concentration, date and freeze–thaw count.
  • Retire any solution that develops haze, particulates or color.

All material discussed here is supplied for laboratory research use only; not for human consumption, not a drug, food or cosmetic.

Related reading

Frequently asked questions

Is there a published shelf life for research-grade semaglutide?

No. No validated shelf life for a research vial reconstituted in water or bacteriostatic water has been published, so a date should not be quoted without a measurement.

What are the main degradation routes for semaglutide?

Hydrolysis, deamidation and isomerization, oxidation and aggregation. Aggregation is a particular concern because the fatty chain makes the peptide surface-active.

Why is powder more stable than solution?

Removing water slows hydrolysis, deamidation and oxidation and restricts molecular motion, so lyophilized material is generally much more stable than solution.

Does bacteriostatic water extend chemical stability?

No. Its preservative limits microbial growth but does not slow chemical degradation of the peptide.

How can a laboratory test stability itself?

Prepare one stock, divide it into identical tubes, store arms at defined temperatures, sample at planned time points and run all samples together on HPLC.

What makes an HPLC method stability-indicating?

It can separate the main peak from degradation products, which is confirmed by forced-degradation samples such as heat- or light-stressed material.

What formula gives percent recovery?

Measured concentration at a time point divided by time-zero concentration, multiplied by 100.

How should the vial be stored according to the product page?

Refrigerate at 2–8 °C, −20 °C for long-term, and protect from heat, moisture and light.

How many freeze–thaw cycles are acceptable?

Plan for one. Freezing concentrates solutes and creates ice interfaces that encourage aggregation, so divide stock into single-use portions.

Where do I calculate the diluent volume?

Use the reconstitution calculator on this site, which applies the vial mass and diluent volume formula.

Related reading: Why Semaglutide Is a Reference GLP-1 Research Peptide, Semaglutide Structure and Albumin Binding for Assays, Semaglutide Preclinical Studies and Stock Math.

References

  1. Lau J, Bloch P, Schäffer L, et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. J Med Chem. 2015;58(18):7370-7380. doi:10.1021/acs.jmedchem.5b00726
  2. Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide. Front Endocrinol (Lausanne). 2019;10:155. doi:10.3389/fendo.2019.00155
  3. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
  4. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. doi:10.1016/S0378-5173(99)00152-0
  5. Hawe A, Wiggenhorn M, van de Weert M, Garbe JHO, Mahler HC, Jiskoot W. Forced degradation of therapeutic proteins. J Pharm Sci. 2012;101(3):895-913. doi:10.1002/jps.22812
  6. Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157
  7. Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
  8. Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. J Biol Chem. 1987;262(2):785-794. doi:10.1016/S0021-9258(19)75855-4

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.